Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal for Immunotherapy of Cancer
|
April 24, 2023
Letter to the editor: Quality criteria for computational models predicting individual outcomes in CAR-T cell therapy
Anna M Mc Laughlin, Cassian Yee
CPT: Pharmacometrics & Systems Pharmacology
|
July 14, 2023
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling
Anna M Mc Laughlin, Peter A Milligan, Cassian Yee, et al.
Hearing Research
|
January 26, 2024
Frequency selectivity in monkey auditory nerve studied with suprathreshold multicomponent stimuli
P X Joris, E Verschooten, M Mc Laughlin, et al.
Clinical Immunology (Orlando, Fla.)
|
May 5, 1999
Possible extrathymic development of nonfunctional T cells in a patient with complete DiGeorge syndrome
H R Collard, A Boeck, T M Mc Laughlin, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
September 23, 2022
Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS
Patrick Opitz, Sebastian Zimmermann, Anna M Mc Laughlin, et al.
BMJ Open
|
August 18, 2021
Cost-effectiveness of oral anticancer drugs and associated individualised dosing approaches in patients with cancer: protocol for a systematic review
Madelé van Dyk, Norma Bulamu, Chelsea Boylan, et al.
BMJ Open
|
January 4, 2022
Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic review
Madelé van Dyk, Chelsea Boylan, Robin Michelet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2024
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)
Ilaria Colombo, Kira-Lee Koster, Lisa Holer, et al.
Cancer Chemotherapy and Pharmacology
|
June 15, 2024
Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial
Anna M Mc Laughlin, Dagmar Hess, Robin Michelet, et al.
Clinical Pharmacokinetics
|
November 18, 2025
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16)
Marian Klose, Ilaria Colombo, Katrin Gobat, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal for Immunotherapy of Cancer
|
April 24, 2023
Letter to the editor: Quality criteria for computational models predicting individual outcomes in CAR-T cell therapy
Anna M Mc Laughlin, Cassian Yee
CPT: Pharmacometrics & Systems Pharmacology
|
July 14, 2023
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling
Anna M Mc Laughlin, Peter A Milligan, Cassian Yee, et al.
Hearing Research
|
January 26, 2024
Frequency selectivity in monkey auditory nerve studied with suprathreshold multicomponent stimuli
P X Joris, E Verschooten, M Mc Laughlin, et al.
Clinical Immunology (Orlando, Fla.)
|
May 5, 1999
Possible extrathymic development of nonfunctional T cells in a patient with complete DiGeorge syndrome
H R Collard, A Boeck, T M Mc Laughlin, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
September 23, 2022
Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS
Patrick Opitz, Sebastian Zimmermann, Anna M Mc Laughlin, et al.
BMJ Open
|
August 18, 2021
Cost-effectiveness of oral anticancer drugs and associated individualised dosing approaches in patients with cancer: protocol for a systematic review
Madelé van Dyk, Norma Bulamu, Chelsea Boylan, et al.
BMJ Open
|
January 4, 2022
Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic review
Madelé van Dyk, Chelsea Boylan, Robin Michelet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2024
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)
Ilaria Colombo, Kira-Lee Koster, Lisa Holer, et al.
Cancer Chemotherapy and Pharmacology
|
June 15, 2024
Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial
Anna M Mc Laughlin, Dagmar Hess, Robin Michelet, et al.
Clinical Pharmacokinetics
|
November 18, 2025
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16)
Marian Klose, Ilaria Colombo, Katrin Gobat, et al.
Page
of 2